TD Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

TD Asset Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-41,200	Closed	-$637K	–	1479
2023 Q1	$637K	Sell	41,200 -2,200	-5%	-$36.7K	﹤0.01%	1219
2022 Q4	$711K	Sell	43,400 -5,300	-11%	-$86.2K	﹤0.01%	1210
2022 Q3	$858K	Buy	48,700 +38,500	+377%	+$604K	﹤0.01%	1212
2022 Q2	$134K	Buy	+10,200	New	+$113K	﹤0.01%	1405
2021 Q4	–	Sell	-14,707	Closed	-$500K	–	1563
2021 Q3	$500K	Hold	14,707	–	–	﹤0.01%	1389
2021 Q2	$448K	Sell	14,707 -10,275	-41%	-$398K	﹤0.01%	1399
2021 Q1	$1.12M	Buy	24,982 +3,063	+14%	+$143K	﹤0.01%	1242
2020 Q4	$1.25M	Hold	21,919	–	–	﹤0.01%	1132
2020 Q3	$1.12M	Sell	21,919 -10,400	-32%	-$509K	﹤0.01%	1069
2020 Q2	$1.93M	Buy	32,319 +2,600	+9%	+$139K	﹤0.01%	882
2020 Q1	$1.22M	Sell	29,719 -2,300	-7%	-$128K	﹤0.01%	950
2019 Q4	$1.99M	Buy	32,019 +21,200	+196%	+$1.01M	﹤0.01%	931
2019 Q3	$367K	Buy	+10,819	New	+$320K	﹤0.01%	1227

Other funds holding DCPH

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TD Asset Management's DCPH Position: Q2 2023 in Review

TD Asset Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2023, closing a stake of 41,200 shares — an estimated $637K sold.

TD Asset Management first reported a position in DCPH in Q3 2019 and held it in 13 quarters. The position peaked at $1.99M in Q4 2019. 145 funds tracked by Wall St. Rank hold DCPH as of Q2 2023.

TD Asset Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
TD Asset Management sold 41,200 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $637K.
TD Asset Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 13 quarters.
TD Asset Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.99M in Q4 2019.
145 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on TD Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.